Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-22-000168
Filing Date
2022-11-09
Accepted
2022-11-09 14:38:31
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 9-30-2022 form10q.htm   iXBRL 10-Q 2092156
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 21066
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 12751
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 12644
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6971
  Complete submission text file 0000874015-22-000168.txt   8750686

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20220930.xsd EX-101.SCH 52346
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20220930_cal.xml EX-101.CAL 83822
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20220930_def.xml EX-101.DEF 302586
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220930_lab.xml EX-101.LAB 808684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220930_pre.xml EX-101.PRE 426458
55 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1509416
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 221372076
SIC: 2834 Pharmaceutical Preparations